Neurological and cardiac events on phenylpropanolamine.
(1) Phenylpropanolamine, or norephedrine, is a sympathomimetic vasoconstrictor very similar to amphetamine, and carries a risk of potentially severe cardiac, neurological and psychiatric events.  (2) One should be aware of the presence of phenylpropanolamine in many non prescription drugs.  (3) Pharmacists should pay special attention to the presence of phenylpropanolamine in freshly prepared slimming mixtures.
D001067:Appetite Depressants / Q000009:adverse effects; D002561:Cerebrovascular Disorders / Q000139:chemically induced; D006331:Heart Diseases / Q000139:chemically induced*; D006801:Humans; D014663:Nasal Decongestants / Q000009:adverse effects; D020258:Neurotoxicity Syndromes; D004366:Nonprescription Drugs / Q000009:adverse effects; D010665:Phenylpropanolamine / Q000009:adverse effects*; D016896:Treatment Outcome
D001067:Appetite Depressants; D014663:Nasal Decongestants; D004366:Nonprescription Drugs; D010665:Phenylpropanolamine